neobookRx
DrugsLevel 4 LocalisationS2TABEML

Orphenadrine Citrate

AnticholinergicMuscle relaxant

Indications

Registered South African indications:

  • Conditions involving skeletal muscle spasm
    - Such as low back pain and torticollis and also those resulting from trauma such as whiplash injury

Cautions

Contraindications

South African recommendations

  • Pregnancy
  • Glaucoma 
  • Tachycardia 
  • Urinary retention 
  • Achalasia 
  • Prostatic hypertrophy 
  • Bladder neck obstruction 
  • Myasthenia gravis 
  • Peptic ulcer stenosing 
  • Pyloric or duodenal obstruction 
  • Porphyria 

Cautions

  • Breastfeeding
  • Hepatic impairment
  • Renal impairment
  • Elderly (particularly males)
  • Micturition difficulties
  • Cardiac insufficiency
  • Tachycardia
  • Heart failure
  • Thyrotoxicosis
  • Abrupt discontinuation

Adult dosage

Forms avail. in SA and covered in this monograph: tab

Dosages below include:

  • South African registered indications and dosages

South African registered indications and dosages

Conditions involving skeletal muscle spasm
- Such as low back pain and torticollis and also those resulting from trauma such as whiplash injury

  • Oral (tab): 100mg, 8-12hrly with water

Paediatric dosage

No information available for children in South Africa

Special populations

Pregnancy

  • Contraindicated
  • Safe use of orphenadrine has not been established with respect to adverse effects on foetal development
  • Orphenadrine citrate should therefore be used in women of childbearing potential and particularly during early pregnancy only when in the judgment of the physician the potential benefits outweigh the possible hazards

Breastfeeding

  • Caution; no information available

Renal Impairment

Hepatic Impairment

Elderly

Porphyria Information

Drugs in Sport

  • Permitted - No warnings

Adverse reactions

Central Nervous System Disorders

  • Dizziness
  • Sedation
  • Confusion
  • Nervousness
  • Hallucinations
  • Convulsions
  • Insomnia
  • Euphoria
  • Memory disturbances
  • Co-ordination disturbances
  • Restlessness

Cardiovascular Disorders

  • Tachycardia

Gastrointestinal Disorders

  • Dry mouth
  • Gastrointestinal disturbances
  • Nausea
  • Constipation

Genitourinary Disorders

  • Urinary retention

Immune System Disorder

  • Hypersensitivity reaction

Sensory Disorders

  • Accommodation disorders

Interactions

  • Antimuscarinic agents

Monitoring

None routine

Mechanism of action

Orphenadrine citrate is a centrally acting anticholinergic. It relaxes skeletal muscle spasms without affecting normal muscle tone. 

Dosage forms

  • Tablet

Formulation

Tablet 100mg

  • Norflex (iNova Pharma) originator

References

1. SAMF_pg411+466 2. PI: Norflex Tablets 100mg, iNova Pharmaceuticals (Pty)Ltd:Date of registration 21 Feb 1985 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 3. PI: Disipal tablets 50mg, iNova Pharmaceuticals (Pty)Ltd:Date of registration 24 Jul 1979 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 4. PI: Phenerine tablets 50mg, Pharmacare (Pty)Ltd:Date of registration Aug 1978 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 5. Drugs.com: Orphenadrine; Downloaded online 26 Nov 2018 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] 6. U2D: Orphenadrine: Drug Information; Uptodate; Downloaded online 16 Aug 2018 [https://drive.google.com/drive/u/0/folders/1eci9ghy0nRSxfat6mOr-3TtneqLfADQo] [https://www.uptodate.com/contents/orphenadrine-drug-information?search=orphenadrine&source=panel_search_result&selectedTitle=1~7&usage_type=panel&kp_tab=drug_general&display_rank=1#F50991304] 7. https://www.medicines.org.uk/emc/medicine/2256 18 September 2012_Astellas_disipal 50mg 8. EMG-Clinical Pharmacologist - Guidelines Review 9. NAPOS The Drug Database for Acute Porphyria: M03BC01 Orphenadrine; Accessed online 04 Sep 2018 [http://www.drugs-porphyria.org/languages/UnitedKingdom/s3.php?atc_code=M03BC01&l=gbr] 10. South African Institute for Drug-Free Sport: Norflex Tablets; Accessed online 04 Sep 2018 [http://www.drugfreesport.org.za/online-medication-check/] 11. SmPC: Orphenadrine Hydrochloride 50mg/5ml Oral Solution, Rosemont Pharmaceuticals Limited: Last updated on eMC: 06 Aug 2013; Downloaded online 11 Dec 2018 [https://www.medicines.org.uk/emc/product/6691] 12. PI: Norflex 100mg Tablets, iNova Pharmaceuticals; Date of revision: 19 Sept 2021; Downloaded: 23 Mar 2023 [https://medsinfoportal.sahpra.org.za/pi/83bd0e36d92bef41fc3af9294c55c6fa.pdf] No SmPC for Orphenadrine citrate checked 29 March 2023

Brands & products

3 products · stale NAPPI snapshot · refreshed 5/28/2026 · 159 days old

tabletGeneric· 3 products

from R2.90/unit
ProductStrengthPackSchedSEPUnitDisp feeNAPPI
Uniflex (was Besenol nc)35 mg50S2R144.86R2.90R62.00881767026
Norflex100 mg50S2R180.31R3.61R74.27747521018
Norflex100 mg20S2R83.00R4.15R40.60747521019
Trade names (1)
  • Norflex

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 16350 · updated 3/30/2023